Advair HFA Information
What's inside Advair HFA
Advair HFA Active Ingredients: fluticasone propionate, salmeterol (as salmeterol xinafoate), details.| Advair HFA Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Advair HFA 45 mcg-21 mcg | aerosol with adapter | inhalation | 1.0 inhalation | OTC |
| Advair HFA 115 mcg-21 mcg | aerosol with adapter | inhalation | 1.0 inhalation | OTC |
| Advair HFA 230 mcg-21 mcg | aerosol with adapter | inhalation | 1.0 inhalation | OTC |
Recent Advair HFA Side Effects
Posted by hrw10730 2 days ago
I lead music for a children's choir and noticed my voice getting weaker over the past year, to the point I could no longer si...
Posted by ralewis 4 days ago
I have adult onset asthma that has gotten progressively worse since I moved from a small Midwestern town to a larger city in ...
Posted by juderedman 4 days ago
I'm officially blown away. My 10 yr old son has been on Advair for a couple of months and strange things have started happeni...
Advair HFA in the News
Pearl Therapeutics, Inc. Expands Its Senior Management Team With ... - SunHerald.com
... products including Advair(R) Diskus(R) and Serevent(R) Diskus(R) for COPD, Serevent(R) and Flovent(R) pediatric programs, Ventolin(R) HFA dose counter, ...
Thu Dec 20 08:44:59 -0500 2007
GSK Supports Emphasis on Asthma Control and Use of Quick ... - PR Newswire (press release)
Advair Diskus is available by prescription only and is approved for the maintenance treatment of asthma in patients four years of age and older. Advair HFA ...
Wed Aug 29 21:08:11 -0400 2007
Commercial Insight: Asthma & COPD - Combination products still ... - Pharmaceutical Business Review
However, combined sales of the Advair franchise (Advair/Seretide and once-daily Beyond Advair) will dominate the asthma/COPD market over the next ten years. ...
Mon Jul 09 18:16:46 -0400 2007
Advair HFA Chemical Information
fluticasone propionate - The propionate salt form of fluticasone, a synthetic trifluorinated glucocorticoid receptor agonist with antiallergic, antiinflammatory and antipruritic effects. Binding and activation of the glucocorticoid receptor results in the activation of lipocortin that in turn inhibits cytosolic phospholipase A2, which triggers cascade of reactions involved in synthesis of inflammatory mediators, such as prostaglandins and leukotrienes. Secondly, mitogen-activated protein kinase (MAPK) phosphatase 1 is induced, thereby leads to dephosphorylation and inactivation of Jun N-terminal kinase directly inhibiting c-Jun mediated transcription. Finally, transcriptional activity of nuclear factor (NF)-kappa-B is blocked, thereby inhibits the transcription of cyclooxygenase 2, which is essential for prostaglandin production.
salmeterol (as salmeterol xinafoate)
Advair HFA RSS Feed